ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
BankPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 109380
SALT LAKE CITY, UT
Position in ALNY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$348,893
-$855,473 QoQ
Shares Held
1,159
-68.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#521
of 780 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 99%
Shared 1%
None 1%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ holds $4,405,667 across 60 Biotechnology names. ALNY ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,341 | $1,162,844 | |
| 2 | VCEL |
Vericel Corp
|
17,369 | $772,746 | |
| 3 | TECH |
BIO-TECHNE Corp
|
9,331 | $659,235 | |
| 4 | INSM |
INSMED Inc
|
3,798 | $404,942 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,159 | $348,893 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
36,247 | $303,387 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,169 | $218,930 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
141 | $87,919 |
All Filings in ALNY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,893 | 1,159 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,204,366 | 3,640 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $58,454 | 147 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,104 | 9 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $210,654 | 646 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $174,432 | 646 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||